Evidence map›Paper›PMID 26393569›Full record

ArticleMolecules (Basel, Switzerland)2015

Clinacanthus nutans (Burm. f.) Lindau Ethanol Extract Inhibits Hepatoma in Mice through Upregulation of the Immune Response.

Danmin Huang, Wenjie Guo, Jing Gao, Jun Chen, Joshua Opeyemi Olatunji

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Antibiotics (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Synergistic effects of combined cisplatin andJournal of Taibah University Medical Sciences · 2023
    Article
  7. Antiviral and Immunomodulatory Activities ofInternational journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Recent Advancement in Anticancer Activity ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  12. Journal of pharmacy & bioallied sciences · 2020
    Article
  13. Subacute Oral Administration ofMolecules (Basel, Switzerland) · 2020
    Article
  14. Article
  15. In Vitro Cytotoxic Activity of Clinacanthus nutans Leaf Extracts Against HeLa CellsAsian Pacific journal of cancer prevention : APJCP · 2019
    Article
  16. Article
  17. A Comprehensive Review on Phytochemistry and Pharmacological Activities ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danmin HuangSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China. danminhuang@126.com.
Wenjie GuoSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China. guowj06@126.com.
Jing GaoSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China. jinggao@mail.ujs.edu.cn.
Jun ChenSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, China. shchen@ujs.edu.cn.
Joshua Opeyemi OlatunjiSchool of Pharmacy, Jiangsu University, Zhenjiang 212013, China. pere@fastermail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinacanthans nutans (Burm. f.) Lindau is a popular medicinal vegetable in Southern Asia, and its extracts have displayed significant anti-proliferative effects on cancer cells in vitro. However, the underlying mechanism for this effect has yet to be established. This study investigated the antitumor and immunomodulatory activity of C. nutans (Burm. f.) Lindau 30% ethanol extract (CN30) in vivo. CN30 was prepared and its main components were identified using high-performance liquid chromatography (HPLC) and mass spectrometry (LC/MS/MS). CN30 had a significant inhibitory effect on tumor volume and weight. Hematoxylin and eosin (H & E) staining and TUNEL assay revealed that hepatoma cells underwent significant apoptosis with CN30 treatment, while expression levels of proliferation markers PCNA and p-AKT were significantly decreased when treated with low or high doses of CN30 treatment. Western blot analysis of PAPR, caspase-3, BAX, and Bcl2 also showed that CN30 induced apoptosis in hepatoma cells. Furthermore, intracellular staining analysis showed that CN30 treatment increased the number of IFN-γ⁺ T cells and decreased the number of IL-4⁺ T cells. Serum IFN-γ and interleukin-2 levels also significantly improved. Our findings indicated that CN30 demonstrated antitumor properties by up-regulating the immune response, and warrants further evaluation as a potential therapeutic agent for the treatment and prevention of cancers.

Indexed as

AcanthaceaeAnimalsAntineoplastic AgentsCarcinoma, HepatocellularChromatography, LiquidEthanolGene Expression Regulation, NeoplasticHepatitis ALiver NeoplasmsMiceMolecular StructurePlant ExtractsTandem Mass SpectrometryXenograft Model Antitumor AssaysAntineoplastic AgentsEthanolPlant ExtractsapoptosisClinacanthus nutansimmunoregulationtumor

Identifiers

PMID26393569
PMCPMC6331932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.